发明授权
US08431607B2 Compounds and compositions as inhibitors of cannabinoid receptor 1 activity
失效
化合物和组合物作为大麻素受体1活性的抑制剂
- 专利标题： Compounds and compositions as inhibitors of cannabinoid receptor 1 activity
- 专利标题（中）： 化合物和组合物作为大麻素受体1活性的抑制剂
-
申请号： US12519147申请日： 2007-12-12
-
公开(公告)号： US08431607B2公开(公告)日： 2013-04-30
- 发明人: Hong Liu , Xiaohui He , Dean Phillips , Xuefeng Zhu , Kunyong Yang , Thomas Lau , Baogen Wu , Yongping Xie , Truc Ngoc Nguyen , Xing Wang
- 申请人： Hong Liu , Xiaohui He , Dean Phillips , Xuefeng Zhu , Kunyong Yang , Thomas Lau , Baogen Wu , Yongping Xie , Truc Ngoc Nguyen , Xing Wang
- 申请人地址： BM Hamilton
- 专利权人： IRM LLC, A Delaware Limited Liability Company
- 当前专利权人： IRM LLC, A Delaware Limited Liability Company
- 当前专利权人地址： BM Hamilton
- 代理机构： Genomics Institute of the Novartis Research Foundation
- 代理商 Chihang Amy Smith
- 国际申请： PCT/US2007/087230 WO 20071212
- 国际公布： WO2008/076754 WO 20080626
- 主分类号： A01N43/50
- IPC分类号： A01N43/50 ; A61K31/415 ; A61K31/50 ; A61K31/501 ; A61K31/497 ; C07D401/00 ; C07D233/00 ; C07D233/02 ; C07D241/00 ; C07D241/02
摘要：
The invention provides compounds, pharmaceutical compositions comprising such compounds and methods of using such compounds to treat or prevent diseases or disorders associated with the activity of Cannabinoid Receptor 1 (CB1).